allele_iedb stringclasses 37
values | allele stringclasses 37
values | peptide stringlengths 7 15 | peptide_length int64 7 15 | measurement_type stringclasses 2
values | measurement_value float64 0 14.3M | measurement_units stringclasses 1
value | assay_method stringclasses 6
values | assay_response stringclasses 2
values | pubmed_id float64 7.51M 37.8M ⌀ | parent_protein stringlengths 3 188 ⌀ | protein_accession stringlengths 6 14 | source_organism stringclasses 849
values | assay_pdb_id float64 | flagged bool 2
classes | has_structures bool 1
class | num_pdbs int64 22 25 | rosetta_best_score float64 -633.25 1.04 | rosetta_mean_score float64 -620.04 44 | pdb_dir stringlengths 24 32 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HLA-A_02_01 | A*02:01 | ILMHCQTTL | 9 | IC50 | 478 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Glutamate decarboxylase 2 | AAH29517.1 | Homo sapiens | null | false | true | 25 | -567.019 | -510.3023 | structures/A0201/ILMHCQTTL |
HLA-A_02_01 | A*02:01 | LLQEYNWEL | 9 | IC50 | 35 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Glutamate decarboxylase 2 | AAH29517.1 | Homo sapiens | null | false | true | 25 | -578.757 | -546.8769 | structures/A0201/LLQEYNWEL |
HLA-A_02_01 | A*02:01 | RMMEYGTTMV | 10 | IC50 | 709 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Glutamate decarboxylase 2 | CAA49554.1 | Homo sapiens | null | false | true | 25 | -539.021 | -505.6863 | structures/A0201/RMMEYGTTMV |
HLA-A_02_01 | A*02:01 | VMNILLQYV | 9 | IC50 | 2,024 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Glutamate decarboxylase 2 | AAH29517.1 | Homo sapiens | null | false | true | 25 | -563.07 | -507.508 | structures/A0201/VMNILLQYV |
HLA-A_02_01 | A*02:01 | VMNILLQYVV | 10 | IC50 | 2,308 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Glutamate decarboxylase 2 | AAH29517.1 | Homo sapiens | null | false | true | 25 | -525.436 | -521.356 | structures/A0201/VMNILLQYVV |
HLA-A_02_01 | A*02:01 | LLDVAPLSL | 9 | IC50 | 51 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 1-like | AAA63228.1 | Homo sapiens | null | false | true | 25 | -566.766 | -529.7419 | structures/A0201/LLDVAPLSL |
HLA-A_02_01 | A*02:01 | LLLLDVAPL | 9 | IC50 | 10 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 1-like | AAA63228.1 | Homo sapiens | null | false | true | 25 | -563.508 | -524.369 | structures/A0201/LLLLDVAPL |
HLA-A_02_01 | A*02:01 | LMGDKSENV | 9 | IC50 | 7,374 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 1B | AAA52697.1 | Homo sapiens | null | false | true | 25 | -534.718 | -483.2217 | structures/A0201/LMGDKSENV |
HLA-A_02_01 | A*02:01 | FIQVYEVERA | 10 | IC50 | 7,024 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 6 | ONTIE_0002836 | Homo sapiens | null | false | true | 25 | -553.967 | -480.687 | structures/A0201/FIQVYEVERA |
HLA-A_02_01 | A*02:01 | FMTSSWWGA | 9 | IC50 | 378 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 6 | ONTIE_0002836 | Homo sapiens | null | false | true | 25 | -564.235 | -506.4217 | structures/A0201/FMTSSWWGA |
HLA-A_02_01 | A*02:01 | FMTSSWWRA | 9 | IC50 | 101 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 6 | ONTIE_0002836 | Homo sapiens | null | false | true | 25 | -554.562 | -488.0698 | structures/A0201/FMTSSWWRA |
HLA-A_02_01 | A*02:01 | FMTSSWWRAPL | 11 | IC50 | 84 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 6 | ONTIE_0002836 | Homo sapiens | null | false | true | 25 | -526.135 | -465.0213 | structures/A0201/FMTSSWWRAPL |
HLA-A_02_01 | A*02:01 | GIPPAPHGV | 9 | IC50 | 219 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 6 | ONTIE_0002836 | Homo sapiens | null | false | true | 25 | -569.256 | -536.196 | structures/A0201/GIPPAPHGV |
HLA-A_02_01 | A*02:01 | GLLQVHHSCPL | 11 | IC50 | 5.8 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 6 | ONTIE_0002836 | Homo sapiens | null | false | true | 25 | -573.722 | -530.2152 | structures/A0201/GLLQVHHSCPL |
HLA-A_02_01 | A*02:01 | GVFIQVYEV | 9 | IC50 | 460 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 6 | ONTIE_0002836 | Homo sapiens | null | false | true | 25 | -561.812 | -499.2432 | structures/A0201/GVFIQVYEV |
HLA-A_02_01 | A*02:01 | KCQEVLAWL | 9 | IC50 | 40,000 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 6 | ONTIE_0002836 | Homo sapiens | null | false | true | 25 | -555.367 | -477.8597 | structures/A0201/KCQEVLAWL |
HLA-A_02_01 | A*02:01 | LLGRFELIGI | 10 | IC50 | 233 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 6 | ONTIE_0002836 | Homo sapiens | null | false | true | 25 | -535.12 | -534.2982 | structures/A0201/LLGRFELIGI |
HLA-A_02_01 | A*02:01 | LLHVHHSCPL | 10 | IC50 | 7,839 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 6 | ONTIE_0002836 | Homo sapiens | null | false | true | 25 | -539.276 | -493.4329 | structures/A0201/LLHVHHSCPL |
HLA-A_02_01 | A*02:01 | LLQVHHSCPL | 10 | IC50 | 3,087 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 6 | ONTIE_0002836 | Homo sapiens | null | false | true | 25 | -552.128 | -516.6377 | structures/A0201/LLQVHHSCPL |
HLA-A_02_01 | A*02:01 | NLLGRFELI | 9 | IC50 | 764 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 6 | ONTIE_0002836 | Homo sapiens | null | false | true | 25 | -564.016 | -523.8556 | structures/A0201/NLLGRFELI |
HLA-A_02_01 | A*02:01 | NLLGRFELIGI | 11 | IC50 | 1.8 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 6 | ONTIE_0002836 | Homo sapiens | null | false | true | 25 | -538.508 | -470.7878 | structures/A0201/NLLGRFELIGI |
HLA-A_02_01 | A*02:01 | SLASLLPHV | 9 | IC50 | 9.1 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 6 | ONTIE_0002836 | Homo sapiens | null | false | true | 25 | -582.753 | -539.7506 | structures/A0201/SLASLLPHV |
HLA-A_02_01 | A*02:01 | SMCRFSPLTL | 10 | IC50 | 1,149 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 6 | ONTIE_0002836 | Homo sapiens | null | false | true | 25 | -576.151 | -514.1142 | structures/A0201/SMCRFSPLTL |
HLA-A_02_01 | A*02:01 | SVASLLPHV | 9 | IC50 | 1,758 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 6 | ONTIE_0002836 | Homo sapiens | null | false | true | 25 | -574.618 | -520.0737 | structures/A0201/SVASLLPHV |
HLA-A_02_01 | A*02:01 | VLNSLASLL | 9 | IC50 | 4,968 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 6 | ONTIE_0002836 | Homo sapiens | null | false | true | 25 | -570.413 | -511.4666 | structures/A0201/VLNSLASLL |
HLA-A_02_01 | A*02:01 | VLNSVASLL | 9 | IC50 | 1,143 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 6 | ONTIE_0002836 | Homo sapiens | null | false | true | 25 | -581.856 | -558.7222 | structures/A0201/VLNSVASLL |
HLA-A_02_01 | A*02:01 | VLVEGSTRI | 9 | IC50 | 17,161 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 6 | ONTIE_0002836 | Homo sapiens | null | false | true | 25 | -565.805 | -534.4868 | structures/A0201/VLVEGSTRI |
HLA-A_02_01 | A*02:01 | SLFEGVDFYT | 10 | IC50 | 51 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock 70 kDa protein 6 | NP_002146.2 | Homo sapiens | null | false | true | 25 | -571.695 | -533.777 | structures/A0201/SLFEGVDFYT |
HLA-A_02_01 | A*02:01 | GIPPAPRGV | 9 | IC50 | 1,226 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Stress-70 protein, mitochondrial | AAH00478.1 | Homo sapiens | null | false | true | 25 | -543.263 | -449.1602 | structures/A0201/GIPPAPRGV |
HLA-A_02_01 | A*02:01 | LIFDLGGGT | 9 | IC50 | 5,416 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock cognate 71 kDa protein | EAL24299.1 | Homo sapiens | null | false | true | 25 | -544.851 | -493.6784 | structures/A0201/LIFDLGGGT |
HLA-A_02_01 | A*02:01 | ILDKKVEKV | 9 | IC50 | 11,237 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Heat shock protein HSP 90-beta | AAH09206.2 | Homo sapiens | null | false | true | 25 | -534.111 | -477.1356 | structures/A0201/ILDKKVEKV |
HLA-A_02_01 | A*02:01 | WGPDPAAA | 8 | IC50 | 40,000 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Insulin | AEG19452.1 | Homo sapiens | null | false | true | 25 | -547.011 | -514.9284 | structures/A0201/WGPDPAAA |
HLA-A_02_01 | A*02:01 | SHLVEALYLV | 10 | IC50 | 2,153 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Insulin | ABI63346.1 | Homo sapiens | null | false | true | 25 | -576.993 | -553.2863 | structures/A0201/SHLVEALYLV |
HLA-A_02_01 | A*02:01 | ALWGPDPAAA | 10 | IC50 | 1,008 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Insulin | ABI63346.1 | Homo sapiens | null | false | true | 25 | -574.694 | -554.7639 | structures/A0201/ALWGPDPAAA |
HLA-A_02_01 | A*02:01 | RLLPLLALLAL | 11 | IC50 | 109 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Insulin | ABI63346.1 | Homo sapiens | null | false | true | 25 | -576.282 | -536.6688 | structures/A0201/RLLPLLALLAL |
HLA-A_02_01 | A*02:01 | HLCGSHLVEA | 10 | IC50 | 7,536 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Insulin | ABI63346.1 | Homo sapiens | null | false | true | 25 | -553.097 | -514.6871 | structures/A0201/HLCGSHLVEA |
HLA-A_02_01 | A*02:01 | FLIVLSVAL | 9 | IC50 | 26 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Islet amyloid polypeptide | CAA39504.1 | Homo sapiens | null | false | true | 25 | -572.198 | -513.0923 | structures/A0201/FLIVLSVAL |
HLA-A_02_01 | A*02:01 | KLQVFLIVL | 9 | IC50 | 1,372 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Islet amyloid polypeptide | CAA39504.1 | Homo sapiens | null | false | true | 25 | -554.07 | -507.2494 | structures/A0201/KLQVFLIVL |
HLA-A_02_01 | A*02:01 | FLWSVFMLI | 9 | IC50 | 26 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Glucose-6-phosphatase 2 | ONTIE_0002097 | Homo sapiens | null | false | true | 25 | -550.056 | -487.4795 | structures/A0201/FLWSVFMLI |
HLA-A_02_01 | A*02:01 | FLWSVFWLI | 9 | IC50 | 55 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Glucose-6-phosphatase 2 | NP_066999.1 | Homo sapiens | null | false | true | 25 | -534.268 | -448.4066 | structures/A0201/FLWSVFWLI |
HLA-A_02_01 | A*02:01 | RLLCALTSL | 9 | IC50 | 91 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Glucose-6-phosphatase 2 | NP_066999.1 | Homo sapiens | null | false | true | 25 | -570.174 | -519.3882 | structures/A0201/RLLCALTSL |
HLA-A_02_01 | A*02:01 | LNIDLLWSV | 9 | IC50 | 684 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Glucose-6-phosphatase 2 | NP_066999.1 | Homo sapiens | null | false | true | 25 | -526.573 | -441.7051 | structures/A0201/LNIDLLWSV |
HLA-A_02_01 | A*02:01 | NLFLFLFAV | 9 | IC50 | 1,228 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Glucose-6-phosphatase 2 | NP_066999.1 | Homo sapiens | null | false | true | 25 | -559.541 | -507.351 | structures/A0201/NLFLFLFAV |
HLA-A_02_01 | A*02:01 | YLLLRVLNI | 9 | IC50 | 57 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Glucose-6-phosphatase 2 | NP_066999.1 | Homo sapiens | null | false | true | 25 | -568.439 | -510.3838 | structures/A0201/YLLLRVLNI |
HLA-A_02_01 | A*02:01 | FLFAVGFYL | 9 | IC50 | 1.1 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Glucose-6-phosphatase 2 | NP_066999.1 | Homo sapiens | null | false | true | 25 | -564.67 | -509.4994 | structures/A0201/FLFAVGFYL |
HLA-A_02_01 | A*02:01 | LLPPLLEHL | 9 | IC50 | 444 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Receptor-type tyrosine-protein phosphatase-like N | NP_002837.1 | Homo sapiens | null | false | true | 25 | -574.917 | -506.0405 | structures/A0201/LLPPLLEHL |
HLA-A_02_01 | A*02:01 | SLAAGVKLL | 9 | IC50 | 3,686 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Receptor-type tyrosine-protein phosphatase-like N | NP_002837.1 | Homo sapiens | null | false | true | 25 | -580.559 | -553.7112 | structures/A0201/SLAAGVKLL |
HLA-A_02_01 | A*02:01 | SLSPLQAEL | 9 | IC50 | 101 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Receptor-type tyrosine-protein phosphatase-like N | NP_002837.1 | Homo sapiens | null | false | true | 25 | -587.487 | -558.0281 | structures/A0201/SLSPLQAEL |
HLA-A_02_01 | A*02:01 | ALTAVAEEV | 9 | IC50 | 1,306 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Receptor-type tyrosine-protein phosphatase N2 | NP_002838.2 | Homo sapiens | null | false | true | 25 | -575.076 | -547.779 | structures/A0201/ALTAVAEEV |
HLA-A_02_01 | A*02:01 | SLYHVYEVNL | 10 | IC50 | 209 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Receptor-type tyrosine-protein phosphatase-like N | NP_002837.1 | Homo sapiens | null | false | true | 25 | -552.907 | -511.4402 | structures/A0201/SLYHVYEVNL |
HLA-A_02_01 | A*02:01 | TIADFWQMV | 9 | IC50 | 4,693 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Receptor-type tyrosine-protein phosphatase-like N | NP_002837.1 | Homo sapiens | null | false | true | 25 | -560.517 | -499.9553 | structures/A0201/TIADFWQMV |
HLA-A_02_01 | A*02:01 | VIVMLTPLV | 9 | IC50 | 2,117 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Receptor-type tyrosine-protein phosphatase-like N | NP_002837.1 | Homo sapiens | null | false | true | 25 | -533.501 | -488.2143 | structures/A0201/VIVMLTPLV |
HLA-A_02_01 | A*02:01 | MVWESGCTV | 9 | IC50 | 126 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Receptor-type tyrosine-protein phosphatase-like N | NP_002837.1 | Homo sapiens | null | false | true | 25 | -574.492 | -520.389 | structures/A0201/MVWESGCTV |
HLA-A_02_01 | A*02:01 | LASEKVYTI | 9 | IC50 | 1,254 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Tyrosine-protein kinase BTK | AAF37333.1 | Homo sapiens | null | false | true | 25 | -566.397 | -501.2605 | structures/A0201/LASEKVYTI |
HLA-A_02_01 | A*02:01 | LMFWSPSHSCA | 11 | IC50 | 143 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Tyrosine-protein kinase Lyn | ONTIE_0002291 | Homo sapiens | null | false | true | 25 | -507.392 | -467.1516 | structures/A0201/LMFWSPSHSCA |
HLA-A_02_01 | A*02:01 | RLQREWHTL | 9 | IC50 | 1,230 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Tyrosine-protein kinase Lyn | ONTIE_0002291 | Homo sapiens | null | false | true | 25 | -571.536 | -527.3059 | structures/A0201/RLQREWHTL |
HLA-A_02_01 | A*02:01 | RLGPVARTRV | 10 | IC50 | 581 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Tyrosine-protein phosphatase non-receptor type 11 | ONTIE_0002586 | Homo sapiens | null | false | true | 25 | -544.989 | -513.9716 | structures/A0201/RLGPVARTRV |
HLA-A_02_01 | A*02:01 | STVASRLGPV | 10 | IC50 | 25,069 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Tyrosine-protein phosphatase non-receptor type 11 | ONTIE_0002586 | Homo sapiens | null | false | true | 25 | -561.894 | -535.1759 | structures/A0201/STVASRLGPV |
HLA-A_02_01 | A*02:01 | STVASWLGPV | 10 | IC50 | 9,227 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Tyrosine-protein phosphatase non-receptor type 11 | ONTIE_0002586 | Homo sapiens | null | false | true | 25 | -543.536 | -515.7792 | structures/A0201/STVASWLGPV |
HLA-A_02_01 | A*02:01 | TLSSRVCCRT | 10 | IC50 | 2,784 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Tyrosine-protein phosphatase non-receptor type 11 | ONTIE_0002586 | Homo sapiens | null | false | true | 25 | -533.957 | -533.1571 | structures/A0201/TLSSRVCCRT |
HLA-A_02_01 | A*02:01 | TVASRLGPV | 9 | IC50 | 7,695 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Tyrosine-protein phosphatase non-receptor type 11 | ONTIE_0002586 | Homo sapiens | null | false | true | 25 | -567.167 | -543.5482 | structures/A0201/TVASRLGPV |
HLA-A_02_01 | A*02:01 | GLPAGAAAQA | 10 | IC50 | 530 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | mRNA decay activator protein ZFP36L1 | ONTIE_0002309 | Homo sapiens | null | false | true | 25 | -580.098 | -536.2822 | structures/A0201/GLPAGAAAQA |
HLA-A_02_01 | A*02:01 | HLSYHRLLPL | 10 | IC50 | 4,259 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | mRNA decay activator protein ZFP36L1 | ONTIE_0002309 | Homo sapiens | null | false | true | 25 | -540.085 | -470.9912 | structures/A0201/HLSYHRLLPL |
HLA-A_02_01 | A*02:01 | HLSYHWLLPL | 10 | IC50 | 3,817 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | mRNA decay activator protein ZFP36L1 | ONTIE_0002309 | Homo sapiens | null | false | true | 25 | -562.032 | -502.1544 | structures/A0201/HLSYHWLLPL |
HLA-A_02_01 | A*02:01 | RLLPLWAAL | 9 | IC50 | 52 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | mRNA decay activator protein ZFP36L1 | ONTIE_0002309 | Homo sapiens | null | false | true | 25 | -543.807 | -478.5494 | structures/A0201/RLLPLWAAL |
HLA-A_02_01 | A*02:01 | RLLPLWAALPL | 11 | IC50 | 5.4 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | mRNA decay activator protein ZFP36L1 | ONTIE_0002309 | Homo sapiens | null | false | true | 25 | -550.093 | -509.84 | structures/A0201/RLLPLWAALPL |
HLA-A_02_01 | A*02:01 | RLRPLCCTA | 9 | IC50 | 8,234 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | mRNA decay activator protein ZFP36L1 | ONTIE_0002309 | Homo sapiens | null | false | true | 25 | -573.195 | -540.7191 | structures/A0201/RLRPLCCTA |
HLA-A_02_01 | A*02:01 | WLLPLWAAL | 9 | IC50 | 4.2 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | mRNA decay activator protein ZFP36L1 | ONTIE_0002309 | Homo sapiens | null | false | true | 25 | -570.537 | -516.5407 | structures/A0201/WLLPLWAAL |
HLA-A_02_01 | A*02:01 | WLLPLWAALPL | 11 | IC50 | 3.2 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | mRNA decay activator protein ZFP36L1 | ONTIE_0002309 | Homo sapiens | null | false | true | 25 | -569.603 | -532.5472 | structures/A0201/WLLPLWAALPL |
HLA-A_02_01 | A*02:01 | ALGDLFQSI | 9 | IC50 | 76 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Proton-coupled zinc antiporter SLC30A8 | ABQ59023.1 | Homo sapiens | null | false | true | 25 | -542.299 | -536.2662 | structures/A0201/ALGDLFQSI |
HLA-A_02_01 | A*02:01 | AVAANIVLTV | 10 | IC50 | 575 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Proton-coupled zinc antiporter SLC30A8 | ABQ59023.1 | Homo sapiens | null | false | true | 25 | -551.863 | -476.6469 | structures/A0201/AVAANIVLTV |
HLA-A_02_01 | A*02:01 | FLLSLFSLWL | 10 | IC50 | 16 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Proton-coupled zinc antiporter SLC30A8 | NP_776250.2 | Homo sapiens | null | false | true | 25 | -577.96 | -506.8589 | structures/A0201/FLLSLFSLWL |
HLA-A_02_01 | A*02:01 | HIAGSLAVV | 9 | IC50 | 216 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Proton-coupled zinc antiporter SLC30A8 | ABQ59023.1 | Homo sapiens | null | false | true | 25 | -562.303 | -529.3051 | structures/A0201/HIAGSLAVV |
HLA-A_02_01 | A*02:01 | ILAVDGVLSV | 10 | IC50 | 2.2 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Proton-coupled zinc antiporter SLC30A8 | ABQ59023.1 | Homo sapiens | null | false | true | 25 | -564.826 | -540.1474 | structures/A0201/ILAVDGVLSV |
HLA-A_02_01 | A*02:01 | ILKDFSILL | 9 | IC50 | 39 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Proton-coupled zinc antiporter SLC30A8 | ABQ59023.1 | Homo sapiens | null | false | true | 25 | -574.646 | -529.3895 | structures/A0201/ILKDFSILL |
HLA-A_02_01 | A*02:01 | ILVLASTITI | 10 | IC50 | 675 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Proton-coupled zinc antiporter SLC30A8 | ABQ59023.1 | Homo sapiens | null | false | true | 25 | -555.974 | -498.8125 | structures/A0201/ILVLASTITI |
HLA-A_02_01 | A*02:01 | IQATVMIIV | 9 | IC50 | 9,043 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Proton-coupled zinc antiporter SLC30A8 | ABQ59023.1 | Homo sapiens | null | false | true | 25 | -548.968 | -515.441 | structures/A0201/IQATVMIIV |
HLA-A_02_01 | A*02:01 | KMYAFTLES | 9 | IC50 | 880 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Proton-coupled zinc antiporter SLC30A8 | NP_776250.2 | Homo sapiens | null | false | true | 25 | -563.858 | -532.7207 | structures/A0201/KMYAFTLES |
HLA-A_02_01 | A*02:01 | RLLYPDYQI | 9 | IC50 | 124 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Proton-coupled zinc antiporter SLC30A8 | ABQ59023.1 | Homo sapiens | null | false | true | 25 | -559.826 | -389.5613 | structures/A0201/RLLYPDYQI |
HLA-A_02_01 | A*02:01 | SISVLISAL | 9 | IC50 | 1,555 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Proton-coupled zinc antiporter SLC30A8 | ABQ59023.1 | Homo sapiens | null | false | true | 25 | -554.852 | -493.2304 | structures/A0201/SISVLISAL |
HLA-A_02_01 | A*02:01 | TMHSLTIQM | 9 | IC50 | 104 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Proton-coupled zinc antiporter SLC30A8 | ABQ59023.1 | Homo sapiens | null | false | true | 25 | -557.744 | -535.9736 | structures/A0201/TMHSLTIQM |
HLA-A_02_01 | A*02:01 | VAANIVLTV | 9 | IC50 | 320 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Proton-coupled zinc antiporter SLC30A8 | ABQ59023.1 | Homo sapiens | null | false | true | 25 | -565.72 | -526.7365 | structures/A0201/VAANIVLTV |
HLA-A_02_01 | A*02:01 | VVTGVLVYL | 9 | IC50 | 9 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Proton-coupled zinc antiporter SLC30A8 | ABQ59023.1 | Homo sapiens | null | false | true | 25 | -550.771 | -500.4458 | structures/A0201/VVTGVLVYL |
HLA-A_02_01 | A*02:01 | LLIDLTSFL | 9 | IC50 | 8.1 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Proton-coupled zinc antiporter SLC30A8 | ABQ59023.1 | Homo sapiens | null | false | true | 25 | -567.825 | -519.8 | structures/A0201/LLIDLTSFL |
HLA-A_02_01 | A*02:01 | LLSILCIWV | 9 | IC50 | 734 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Proton-coupled zinc antiporter SLC30A8 | ABQ59023.1 | Homo sapiens | null | false | true | 25 | -559.334 | -497.6362 | structures/A0201/LLSILCIWV |
HLA-A_02_01 | A*02:01 | LLSLFSLWL | 9 | IC50 | 152 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Proton-coupled zinc antiporter SLC30A8 | NP_776250.2 | Homo sapiens | null | false | true | 25 | -556.859 | -507.2606 | structures/A0201/LLSLFSLWL |
HLA-A_02_01 | A*02:01 | QHLCGSHLV | 9 | IC50 | 40,000 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Insulin | P01308.1 | Homo sapiens | null | false | true | 25 | -547.684 | -499.7503 | structures/A0201/QHLCGSHLV |
HLA-A_02_01 | A*02:01 | LVEALYLVC | 9 | IC50 | 11,770 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 29,562,882 | Insulin | P01308.1 | Homo sapiens | null | false | true | 25 | -565.058 | -539.9019 | structures/A0201/LVEALYLVC |
HLA-A_02_01 | A*02:01 | ELQTTIHDI | 9 | IC50 | 36,900 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 29,603,667 | Protein E6 | AAD33252.1 | Human papillomavirus 16 | null | false | true | 25 | -544.991 | -522.2344 | structures/A0201/ELQTTIHDI |
HLA-A_02_01 | A*02:01 | TLHEYMLDLQP | 11 | IC50 | 19,350 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 29,603,667 | Protein E7 | AAD33253.1 | Human papillomavirus 16 | null | false | true | 25 | -580.909 | -545.7491 | structures/A0201/TLHEYMLDLQP |
HLA-A_02_01 | A*02:01 | EYMLDLQPET | 10 | IC50 | 45,260 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 29,603,667 | Protein E7 | AAD33253.1 | Human papillomavirus 16 | null | false | true | 25 | -551.27 | -524.7394 | structures/A0201/EYMLDLQPET |
HLA-A_02_01 | A*02:01 | YMLDLQPE | 8 | IC50 | 8,070 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 29,603,667 | Protein E7 | AAD33253.1 | Human papillomavirus 16 | null | false | true | 25 | -546.412 | -493.0899 | structures/A0201/YMLDLQPE |
HLA-A_02_01 | A*02:01 | YMLDLQPETTD | 11 | IC50 | 2,370 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 29,603,667 | Protein E7 | AAD33253.1 | Human papillomavirus 16 | null | false | true | 25 | -568.849 | -506.6286 | structures/A0201/YMLDLQPETTD |
HLA-A_02_01 | A*02:01 | MLDLQPET | 8 | IC50 | 53,660 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 29,603,667 | Protein E7 | AAD33253.1 | Human papillomavirus 16 | null | false | true | 25 | -564.123 | -510.969 | structures/A0201/MLDLQPET |
HLA-A_02_01 | A*02:01 | IRTLEDLLMGT | 11 | IC50 | 31,850 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 29,603,667 | Protein E7 | AAD33253.1 | Human papillomavirus 16 | null | false | true | 25 | -539.183 | -512.7204 | structures/A0201/IRTLEDLLMGT |
HLA-A_02_01 | A*02:01 | RTLEDLLMGT | 10 | IC50 | 66,940 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 29,603,667 | Protein E7 | AAD33253.1 | Human papillomavirus 16 | null | false | true | 25 | -575.23 | -510.4201 | structures/A0201/RTLEDLLMGT |
HLA-A_02_01 | A*02:01 | RTLEDLLMGTL | 11 | IC50 | 2,690 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 29,603,667 | Protein E7 | AAD33253.1 | Human papillomavirus 16 | null | false | true | 25 | -555.858 | -508.2437 | structures/A0201/RTLEDLLMGTL |
HLA-A_02_01 | A*02:01 | TLEDLLMGT | 9 | IC50 | 64,630 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 29,603,667 | Protein E7 | AAD33253.1 | Human papillomavirus 16 | null | false | true | 25 | -567.962 | -518.7684 | structures/A0201/TLEDLLMGT |
HLA-A_02_01 | A*02:01 | EDLLMGTLGIV | 11 | IC50 | 14,200 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 29,603,667 | Protein E7 | AAD33253.1 | Human papillomavirus 16 | null | false | true | 25 | -570.293 | -547.5346 | structures/A0201/EDLLMGTLGIV |
HLA-A_02_01 | A*02:01 | DLLMGTLGIV | 10 | IC50 | 80,990 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 29,603,667 | Protein E7 | AAD33253.1 | Human papillomavirus 16 | null | false | true | 25 | -512.307 | -511.6243 | structures/A0201/DLLMGTLGIV |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.